Bayer AG Challenges Nexavar Generic Licence Order

Drugmaker Bayer has filed an appeal against an Indian Patents Office's order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German firm's cancer drug 'Nexavar' in Ind…
Read the full story: BioSpace.com Featured News